S. Adler, D. Basketter, S. Creton, O. Pelkonen, J. Van-benthem et al., Alternative (non-animal) methods for cosmetics testing: current status and future prospects???2010, Archives of Toxicology, vol.277, issue.6, pp.367-485, 2011.
DOI : 10.1016/j.tox.2010.08.016

URL : https://hal.archives-ouvertes.fr/ineris-00963274

J. W. Allen and S. N. Bhatia, Formation of steady-state oxygen gradients in vitro:Application to liver zonation, Biotechnology and Bioengineering, vol.73, issue.3, pp.253-262, 2003.
DOI : 10.1002/bit.1071

M. E. Andersen, L. S. Birnbaum, H. A. Barton, and C. R. Eklund, Regional Hepatic CYP1A1 and CYP1A2 Induction with 2,3,7,8-Tetrachlorodibenzo-p-dioxin Evaluated with a Multicompartment Geometric Model of Hepatic Zonation, Toxicology and Applied Pharmacology, vol.144, issue.1, pp.145-155, 1997.
DOI : 10.1006/taap.1996.8067

I. Anundi, T. Lähteenmäki, M. Rundgren, P. Moldeus, and K. O. Lindros, Zonation of acetaminophen metabolism and cytochrome P450 2E1-mediated toxicity studied in isolated periportal and perivenous hepatocytes, Biochemical Pharmacology, vol.45, issue.6, pp.1251-1259, 1993.
DOI : 10.1016/0006-2952(93)90277-4

P. Armitage, Multistage models of carcinogenesis, Environmental Health Perspectives, vol.63, pp.195-201, 1985.
DOI : 10.1289/ehp.8563195

J. M. Armitage, F. Wania, and J. A. Arnot, Application of Mass Balance Models and the Chemical Activity Concept To Facilitate the Use of in Vitro Toxicity Data for Risk Assessment, Environmental Science & Technology, vol.48, issue.16, pp.9770-9779, 2014.
DOI : 10.1021/es501955g

J. B. Bassingthwaighte, Strategies for the Physiome Project, Annals of Biomedical Engineering, vol.28, issue.8, pp.1043-1058, 2000.
DOI : 10.1114/1.1313771

R. Beaudouin, S. Micallef, and C. Brochot, A stochastic whole-body physiologically based pharmacokinetic model to assess the impact of interindividual variability on tissue dosimetry over the human lifespan. Regul, Toxicol. Pharm, vol.57, pp.103-116, 2010.
URL : https://hal.archives-ouvertes.fr/ineris-00963225

M. R. Berthold, N. Cebron, F. Dill, T. R. Gabriel, T. Kötter et al., KNIME: The Konstanz Information Miner, Studies in Classification, Data Analysis, and Knowledge Organization, 2007.
DOI : 10.1007/978-3-540-78246-9_38

J. G. Bessems, G. Loizou, K. Krishnan, I. Clewell, H. J. Bernasconi et al., PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment, Regulatory Toxicology and Pharmacology, vol.68, issue.1, pp.119-139, 2014.
DOI : 10.1016/j.yrtph.2013.11.008

URL : https://hal.archives-ouvertes.fr/ineris-01855482

F. Y. Bois, Physiologically Based Modelling and Prediction of Drug Interactions, Basic & Clinical Pharmacology & Toxicology, vol.31, issue.9, pp.154-161, 2009.
DOI : 10.18637/jss.v002.i09

F. Y. Bois, M. Jamei, and H. J. Clewell, PBPK modelling of inter-individual variability in the pharmacokinetics of environmental chemicals, Toxicology, vol.278, issue.3, pp.256-267, 2010.
DOI : 10.1016/j.tox.2010.06.007

URL : https://hal.archives-ouvertes.fr/ineris-00961755

S. Coecke, O. Pelkonen, S. Batista-leite, U. Bernauer, J. Bessems et al., Toxicokinetics as a key to the integrated toxicity risk assessment based primarily on non-animal approaches, Toxicology in Vitro, vol.27, issue.5, pp.1570-1577, 2012.
DOI : 10.1016/j.tiv.2012.06.012

URL : https://hal.archives-ouvertes.fr/ineris-00963488

R. A. Corley, Pharmacokinetics and PBPK Models, Comprehensive Toxicology, pp.27-58, 2010.
DOI : 10.1016/B978-0-08-046884-6.01505-0

D. Crean, P. Bellwon, L. Aschauer, A. Limonciel, K. Moenks et al., Development of an in vitro renal epithelial disease state model for xenobiotic toxicity testing, Toxicology in Vitro, vol.30, issue.1, pp.128-137, 2014.
DOI : 10.1016/j.tiv.2014.11.015

URL : https://hal.archives-ouvertes.fr/ineris-01855196

K. S. Crump and R. B. Howe, The multistage model with a time-dependent dose pattern: applications to carcinogenic risk assessment, Risk Anal, vol.4, pp.163-176, 1984.

C. Csajka and D. Verotta, Pharmacokinetic???Pharmacodynamic Modelling: History and Perspectives, Journal of Pharmacokinetics and Pharmacodynamics, vol.21, issue.3, pp.227-279, 2006.
DOI : 10.1146/annurev.pa.32.040192.001153

A. Dash, W. Inman, K. Hoffmaster, S. Sevidal, J. Kelly et al., Liver tissue engineering in the evaluation of drug safety, Expert Opinion on Drug Metabolism & Toxicology, vol.13, issue.10, pp.1159-1174, 2009.
DOI : 10.1039/b901377f

D. Ochoa, J. G. Bucher, J. Péry, A. R. Zaldivar-comenges, J. M. Niklas et al., A multi-scale modeling framework for individualized, spatiotemporal prediction of drug effects and toxicological risk, Front. Pharmacol, vol.3, p.204, 2013.
URL : https://hal.archives-ouvertes.fr/ineris-00961795

A. Dokoumetzidis and P. Macheras, A Model for Transport and Dispersion in the Circulatory System Based on the Vascular Fractal Tree, Annals of Biomedical Engineering, vol.31, issue.3, pp.284-293, 2003.
DOI : 10.1114/1.1555627

M. L. Dourson and S. P. Felter, Route-to-Route Extrapolation of the Toxic Potency of MTBE, Risk Analysis, vol.12, issue.2, pp.717-725, 1997.
DOI : 10.1080/10590509409373434

D. Drasdo, S. Hoehme, and J. G. Hengstler, How predictive quantitative modelling of tissue organisation can inform liver disease pathogenesis, Journal of Hepatology, vol.61, issue.4, pp.951-956, 2014.
DOI : 10.1016/j.jhep.2014.06.013

M. Gajewska, A. Worth, C. Urani, H. Briesen, and K. Schramm, Application of physiologically-based toxicokinetic modelling in oral-to-dermal extrapolation of threshold doses of cosmetic ingredients, Toxicology Letters, vol.227, issue.3, pp.189-202, 2014.
DOI : 10.1016/j.toxlet.2014.03.013

M. Gajewska, A. Paini, J. V. Sala-benito, J. Burton, A. Worth et al., In vitro-to-in vivo correlation of the skin penetration, liver clearance and hepatotoxicity of caffeine, Food and Chemical Toxicology, vol.75, pp.39-49, 2015.
DOI : 10.1016/j.fct.2014.10.017

R. Gebhardt and M. Matz-soja, Liver zonation: Novel aspects of its regulation and its impact on homeostasis, World Journal of Gastroenterology, vol.20, issue.26, p.8491, 2014.
DOI : 10.3748/wjg.v20.i26.8491

S. Geenen, P. N. Taylor, J. L. Snoep, I. D. Wilson, J. G. Kenna et al., Systems biology tools for toxicology, Archives of Toxicology, vol.3, issue.3, pp.1251-1271, 2012.
DOI : 10.1006/mben.2001.0187

URL : https://pure.uva.nl/ws/files/1632032/117582_378196.pdf

S. Geenen, J. W. Yates, J. G. Kenna, F. Y. Bois, I. D. Wilson et al., Multiscale modelling approach combining a kinetic model of glutathione metabolism with PBPK models of paracetamol and the potential glutathione-depletion biomarkers ophthalmic acid and 5-oxoproline in humans and rats, Integrative Biology, vol.85, issue.1, pp.877-888, 2013.
DOI : 10.1177/074823379701300401

URL : https://hal.archives-ouvertes.fr/ineris-00963501

T. R. Gerrity and C. J. Henry, Principles of Route-to-Route Extrapolation for Risk Assessment, 1990.

M. Gibaldi and D. Perrier, , 1982.

J. W. Grisham, Organizational principles of the liver The Liver, pp.1-15, 2009.

A. Guillouzo, A. Corlu, C. Aninat, D. Glaise, F. Morel et al., The human hepatoma HepaRG cells: A highly differentiated model for studies of liver metabolism and toxicity of xenobiotics, Chemico-Biological Interactions, vol.168, issue.1, pp.66-73, 2007.
DOI : 10.1016/j.cbi.2006.12.003

J. Hamon, P. Jennings, and F. Y. Bois, Systems biology modeling of omics data: effect of cyclosporine a on the Nrf2 pathway in human renal cells, BMC Systems Biology, vol.8, issue.1, p.76, 2014.
DOI : 10.1186/1752-0509-8-76

URL : https://hal.archives-ouvertes.fr/ineris-01862454

J. Hamon, M. Renner, M. Jamei, A. Lukas, A. Kopp-schneider et al., Quantitative in vitro to in vivo extrapolation of tissues toxicity, Toxicology in Vitro, vol.30, issue.1, pp.203-216, 2015.
DOI : 10.1016/j.tiv.2015.01.011

URL : https://hal.archives-ouvertes.fr/ineris-01855034

H. Holzhütter, D. Drasdo, T. Preusser, J. Lippert, and A. M. Henney, The virtual liver: a multidisciplinary, multilevel challenge for systems biology, Wiley Interdisciplinary Reviews: Systems Biology and Medicine, vol.10, issue.3, pp.221-235, 2012.
DOI : 10.1038/embor.2009.132

C. A. Hunt and G. E. Ropella, Using an In Silico Liver to evaluate a hepatic enzyme induction mechanism, 2008 30th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, pp.2415-2418, 2008.
DOI : 10.1109/IEMBS.2008.4649686

P. J. Hunter and T. K. Borg, Integration from proteins to organs: the Physiome Project, Nature Reviews Molecular Cell Biology, vol.28, issue.3, pp.237-243, 2003.
DOI : 10.1145/192161.192200

M. Jamei, S. Marciniak, K. R. Feng, A. Barnett, G. Tucker et al., Population-based ADME Simulator, Expert Opinion on Drug Metabolism & Toxicology, vol.45, issue.2, pp.211-223, 2009.
DOI : 10.1080/00498250701620726

H. M. Jones, H. A. Barton, Y. Lai, Y. A. Bi, E. Kimoto et al., Mechanistic Pharmacokinetic Modeling for the Prediction of Transporter-Mediated Disposition in Humans from Sandwich Culture Human Hepatocyte Data, Drug Metabolism and Disposition, vol.40, issue.5, pp.1007-1017, 2012.
DOI : 10.1124/dmd.111.042994

W. J. Jusko, Moving from Basic Toward Systems Pharmacodynamic Models, Journal of Pharmaceutical Sciences, vol.102, issue.9, pp.2930-2940, 2013.
DOI : 10.1002/jps.23590

H. Kimura, T. Ikeda, H. Nakayama, Y. Sakai, and T. Fujii, An On-Chip Small Intestine???Liver Model for Pharmacokinetic Studies, Journal of Laboratory Automation, vol.17, issue.3, pp.265-273, 2015.
DOI : 10.20965/jrm.2010.p0594

M. Krauss, S. Schaller, S. Borchers, R. Findeisen, J. Lippert et al., Integrating Cellular Metabolism into a Multiscale Whole-Body Model, PLoS Computational Biology, vol.21, issue.10, 2012.
DOI : 10.1371/journal.pcbi.1002750.s001

R. Kroes, A. G. Renwick, V. Feron, C. L. Galli, M. Gibney et al., Application of the threshold of toxicological concern (TTC) to the safety evaluation of cosmetic ingredients, Food and Chemical Toxicology, vol.45, issue.12, pp.2533-2562, 2007.
DOI : 10.1016/j.fct.2007.06.021

H. Lodish, Molecular Cell Biology, 2000.

S. A. Martin, E. D. Mclanahan, P. J. Bushnell, E. S. Hunter, and H. El-masri, Species Extrapolation of Life-Stage Physiologically-Based Pharmacokinetic (PBPK) Models to Investigate the Developmental Toxicology of Ethanol Using In vitro to In vivo (IVIVE) Methods, Toxicological Sciences, vol.112, issue.2, pp.512-535, 2015.
DOI : 10.1016/0002-9378(72)90784-3

P. Mitchell and J. Moyle, Estimation of Membrane Potential and pH Difference across the Cristae Membrane of Rat Liver Mitochondria, European Journal of Biochemistry, vol.38, issue.4, pp.471-484, 1969.
DOI : 10.1042/bj0760179

S. H. Moolgavkar and A. G. Knudson-jr, Mutation and Cancer: A Model for Human Carcinogenesis2, JNCI: Journal of the National Cancer Institute, vol.66, issue.6, pp.1037-1052, 1981.
DOI : 10.1093/jnci/66.6.1037

A. Mostrag-szlichtyng and A. Worth, Review of QSAR Models and Software Tools for Predicting Biokinetic Properties, JRC Institute for Health and Consumer Protection, 2010.

I. C. Munro, R. A. Ford, E. Kennepohl, and J. G. Sprenger, Correlation of structural class with no-observed-effect levels: A proposal for establishing a threshold of concern, Food and Chemical Toxicology, vol.34, issue.9, pp.829-867, 1996.
DOI : 10.1016/S0278-6915(96)00049-X

, Toxicity Testing in the 21st Century: A Vision and A Strategy, National Research Council, 2007.

D. G. Nicholls and M. W. Ward, Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts, Trends in Neurosciences, vol.23, issue.4, pp.166-174, 2000.
DOI : 10.1016/S0166-2236(99)01534-9

E. Nielsen, G. Østergaard, and J. C. Larsen, Toxicological Risk Assessment of Chemicals. Informa Healthcare, 2008.

T. Oinonen and K. O. Lindros, Zonation of hepatic cytochrome P-450 expression and regulation, Biochemical Journal, vol.329, issue.1, pp.17-35, 1998.
DOI : 10.1042/bj3290017

S. Ostrovidov, J. Jiang, Y. Sakai, and T. Fujii, Membrane-Based PDMS Microbioreactor for Perfused 3D Primary Rat Hepatocyte Cultures, Biomedical Microdevices, vol.6, issue.4, pp.279-287, 2004.
DOI : 10.1023/B:BMMD.0000048560.96140.ca

D. A. Ouattara, S. H. Choi, Y. Sakai, A. R. Péry, and C. Brochot, Kinetic modelling of in vitro cell-based assays to characterize non-specific bindings and ADME processes in a static and a perfused fluidic system, Toxicology Letters, vol.205, issue.3, pp.310-319, 2011.
DOI : 10.1016/j.toxlet.2011.06.021

URL : https://hal.archives-ouvertes.fr/ineris-00963306

F. Y. Bois, Multiscale modelling approaches for assessing cosmetic ingredients safety, Toxicology, vol.392, pp.130-139, 2017.
DOI : 10.1016/j.tox.2016.05.026

URL : https://hal.archives-ouvertes.fr/ineris-01863940

A. Péry, C. Brochot, F. A. Zeman, E. Mombelli, S. Desmots et al., Prediction of dose-hepatotoxic response in humans based on toxicokinetic/toxicodynamic modeling with or without in vivo data: A case study with acetaminophen, Toxicology Letters, vol.220, issue.1, pp.26-34, 2013.
DOI : 10.1016/j.toxlet.2013.03.032

A. Paini, A. Punt, G. Scholz, E. Gremaud, B. Spenkelink et al., In vivo validation of DNA adduct formation by estragole in rats predicted by physiologically based biodynamic modelling, Mutagenesis, vol.180, issue.6, pp.653-663, 2012.
DOI : 10.1016/j.toxlet.2008.05.021

K. S. Pang and M. Rowland, Hepatic clearance of drugs. I. Theoretical considerations of a ???well-stirred??? model and a ???parallel tube??? model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance, Journal of Pharmacokinetics and Biopharmaceutics, vol.36, issue.6, pp.625-653, 1977.
DOI : 10.1002/jps.2600640120

K. S. Pang, M. Weiss, and P. Macheras, Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal concepts, The AAPS Journal, vol.9, issue.2, pp.268-283, 2007.
DOI : 10.1208/aapsj0902030

URL : http://europepmc.org/articles/pmc2751417?pdf=render

S. A. Peters, Physiologically Based Pharmacokinetic (pbpk) Modeling and Simulations: Principles, Methods, and Applications in the Pharmaceutical Industry, 2011.
DOI : 10.1002/9781118140291

I. Poggesi, J. Snoeys, and A. Van-peer, The successes and failures of physiologically based pharmacokinetic modeling: there is room for improvement, Expert Opinion on Drug Metabolism & Toxicology, vol.18, issue.5, pp.631-635, 2014.
DOI : 10.1002/bdd.1776

G. Pomponio, C. C. Savary, C. Parmentier, F. Bois, A. Guillouzo et al., In vitro kinetics of amiodarone and its major metabolite in two human liver cell models after acute and repeated treatments, Toxicology in Vitro, vol.30, issue.1, pp.36-51, 2014.
DOI : 10.1016/j.tiv.2014.12.012

URL : https://hal.archives-ouvertes.fr/hal-01134698

N. Quignot, J. Hamon, and F. Y. Bois, Extrapolating In Vitro Results to Predict Human Toxicity, Vitro Toxicology Systems, pp.531-550, 2014.
DOI : 10.1007/978-1-4939-0521-8_24

URL : https://hal.archives-ouvertes.fr/ineris-01852921

R. Development and C. Team, R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, 2013.

R. H. Reitz, J. N. Macdougal, M. W. Himmelstein, R. J. Nolan, and A. M. Schumann, Physiologically based pharmacokinetic modeling with methylchloroform: implications for interspecies, high dose/low dose, and dose route extrapolations, Toxicology and Applied Pharmacology, vol.95, issue.2, pp.185-199, 1988.
DOI : 10.1016/0041-008X(88)90155-X

I. M. Rietjens, J. Louisse, and A. Punt, Tutorial on physiologically based kinetic modeling in molecular nutrition and food research, Molecular Nutrition & Food Research, vol.1150, issue.6, pp.941-956, 2011.
DOI : 10.1002/tera.1420320106

G. E. Ropella and C. A. Hunt, Cloud computing and validation of expandable in silico livers, BMC Systems Biology, vol.4, issue.1, p.168, 2010.
DOI : 10.1186/1752-0509-4-168

URL : https://bmcsystbiol.biomedcentral.com/track/pdf/10.1186/1752-0509-4-168?site=bmcsystbiol.biomedcentral.com

V. Y. Soldatow, E. L. Lecluyse, L. G. Griffith, and I. Rusyn, In vitro models for liver toxicity testing, vitro models for liver toxicity testing, pp.23-39, 2013.
DOI : 10.1038/nbt.1554

URL : http://europepmc.org/articles/pmc3593300?pdf=render

S. Teng, S. Barcellini-couget, R. Beaudouin, C. Brochot, G. Desousa et al., BK/TD models for analyzing in vitro impedance data on cytotoxicity, BK/TD models for analyzing in vitro impedance data on cytotoxicity, pp.96-106, 2015.
DOI : 10.1016/j.toxlet.2015.03.011

URL : https://hal.archives-ouvertes.fr/hal-01146616

K. E. Tollefsen, S. Scholz, M. T. Cronin, S. W. Edwards, J. De-knecht et al., Applying adverse outcome pathways (AOPs) to support integrated approaches to testing and assessment (IATA). Regul, Toxicol. Pharm, vol.70, pp.629-640, 2014.
DOI : 10.1016/j.yrtph.2014.09.009

URL : https://doi.org/10.1016/j.yrtph.2014.09.009

S. Trapp, G. R. Rosania, R. W. Horobin, and J. Kornhuber, Quantitative modeling of selective lysosomal targeting for drug design, European Biophysics Journal, vol.3, issue.8, pp.1317-1328, 2008.
DOI : 10.1111/j.1365-2818.1991.tb03175.x

URL : http://europepmc.org/articles/pmc2711917?pdf=render

G. L. Truisi, E. D. Consiglio, C. Parmentier, C. C. Savary, G. Pomponio et al., Understanding the biokinetics of ibuprofen after single and repeated treatments in rat and human in vitro liver cell systems, Toxicology Letters, vol.233, issue.2, pp.172-186, 2015.
DOI : 10.1016/j.toxlet.2015.01.006

URL : https://hal.archives-ouvertes.fr/hal-01134674

, Next Generation Risk Assessment: Incorporation of Recent Advances in Molecular, Computational, and Systems Biology, 2014.

B. Vollmar and M. D. Menger, The Hepatic Microcirculation: Mechanistic Contributions and Therapeutic Targets in Liver Injury and Repair, Physiological Reviews, vol.89, issue.4, pp.1269-1339, 2009.
DOI : 10.1016/0026-2862(73)90051-4

J. Wambaugh and I. Shah, Simulating Microdosimetry in a Virtual Hepatic Lobule, PLoS Computational Biology, vol.128, issue.4, 2010.
DOI : 10.1371/journal.pcbi.1000756.t003

S. Willmann, K. Höhn, A. Edginton, M. Sevestre, J. Solodenko et al., Development of a Physiology-Based Whole-Body Population Model for Assessing the Influence of Individual Variability on the Pharmacokinetics of Drugs, Journal of Pharmacokinetics and Pharmacodynamics, vol.38, issue.2, pp.401-431, 2007.
DOI : 10.5414/CPP38053

A. Wilmes, A. Limonciel, L. Aschauer, K. Moenks, C. Bielow et al., Application of integrated transcriptomic, proteomic and metabolomic profiling for the delineation of mechanisms of drug induced cell stress, Journal of Proteomics, vol.79, pp.180-194, 2013.
DOI : 10.1016/j.jprot.2012.11.022

URL : https://hal.archives-ouvertes.fr/ineris-00963456

A. Worth, M. Fuart-gatnik, S. Lapenna, E. Lo-piparo, A. Mostrag-szlichtyng et al., The Use of Computational Methods in the Toxicological Assessment of Chemicals in Food: Current Status and Future Prospects, JRC Institute for Health and Consumer Protection, 2011.

A. Worth, M. Cronin, S. Enoch, E. Fioravanzo, M. Fuart-gatnik et al., Applicability of the Threshold of Toxicological Concern (TTC) Approach to Cosmetics?Preliminary Analysis, JRC Institute for Health and Consumer Protection, 2012.

J. Z. Xing, L. Zhu, S. Gabos, and L. Xie, Microelectronic cell sensor assay for detection of cytotoxicity and prediction of acute toxicity, Toxicology in Vitro, vol.20, issue.6, pp.995-1004, 2006.
DOI : 10.1016/j.tiv.2005.12.008

J. M. Zaldívar, M. Mennecozzi, R. Rodrigues, and M. Bouhifd, A Biology-based Dynamic Approach for the Modelling of Toxicity in Cell-based Assays. Part I: Fate Modelling, JRC Institute for Health and Consumer Protection, 2010.

J. Zaldívar, M. Mennecozzi, P. Macko, R. Rodrigues, M. Bouhifd et al., A Biology-based Dynamic Approach for the Modelling of Toxicity in Cell Assays. Part II: Models for Cell Population Growth and Toxicity, JRC Institute for Health and Consumer Protection, 2011.